A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is ...

Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA ...

DARPins as pan-reactivators of temperature-sensitive p53 cancer mutants. Proceedings of the National Academy of Sciences, PNAS (2026) ...

Each year, 20 million people are diagnosed with cancer. Various organs can be affected, and cancer types sometimes differ greatly at the cellular and ...

If you’re a pet owner, and planning to relocate to or from the UAE, it’s important to ensure all your documents are in order, and all required procedures have b ...

Pfizer Inc. today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) ...

As potentially deadly avian influenza (H5N1) continues its global spread, moving from birds into mammals and in rare cases ...

With exports set to commence from June 2026, Lord's Mark will enter key international markets across Africa, Europe, and Latin America regions that are witnessing a structural shift toward ...

For more than a decade, veterinary researchers in Queensland, Australia, have been vaccinating wild koalas against chlamydia, ...

Plans have been unveiled for a major new medical research hub in Southampton.

Duke has won federal funding to lead a national HIV vaccine research consortium since 2005. Now the National Institutes of Health is ending its grant.

The 510(k) clearances were granted to a dozen in vitro diagnostic tests and reagents which used a variety of detection methods and approaches.